SCHEMBL31528007

SCHEMBL31528007

C=C(Cc1nc(-c2ccc(Oc3cnccn3)cc2)no1)C(=O)O

nearest known ligand 0.43

Predicted protein targets (top 15)

geneUniProtsupporting neighboursconfidence
▸ MITF O75030 1/20 0.43
▸ TP53 P04637 1/20 0.43
▸ NCOA3 Q9Y6Q9 1/20 0.43
▸ LMNA P02545 2/20 0.42
▸ ATM Q13315 1/20 0.42
▸ KMT2A Q03164 1/20 0.41
▸ PSMB5 P28074 1/20 0.41
▸ KDM4E B2RXH2 1/20 0.40
▸ LTA4H P09960 1/20 0.40
▸ ACACB O00763 1/20 0.39
▸ RAB9A P51151 1/20 0.39
▸ FFAR1 O14842 5/20 0.39
▸ GSTP1 P09211 2/20 0.39
▸ SMN1; SMN2 Q16637 1/20 0.39
▸ MAPT P10636 1/20 0.39

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL30689347 0.86 IP6K1 (0.48) MITFTP53NCOA3LMNAATM
SCHEMBL31527955 0.85 LMNA (0.46) MITFTP53NCOA3LMNAATM
SCHEMBL31527948 0.84 PSMB5 (0.49) TP53LMNAATMKMT2APSMB5
SCHEMBL30689328 0.84 FFAR1 (0.43) MITFTP53NCOA3LMNAATM
SCHEMBL31527827 0.83 TP53 (0.46) MITFTP53NCOA3LMNAATM
SCHEMBL30689438 0.82 LMNA (0.51) MITFTP53NCOA3LMNAATM
SCHEMBL30689370 0.82 TP53 (0.42) MITFTP53NCOA3LMNAATM
SCHEMBL30689340 0.82 GSTP1 (0.41) MITFTP53NCOA3LMNAATM
SCHEMBL30689423 0.81 TP53 (0.41) MITFTP53NCOA3LMNAATM
SCHEMBL31527959 0.81 LMNA (0.42) MITFTP53NCOA3LMNAATM

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-119968366-A Oxadiazole derivatives, methods of preparation and use thereof in the treatment of inflammatory diseases 西特瑞治疗有限公司 2025-05-09 — — CN claimed
CN-119968366-A Oxadiazole derivatives, methods of preparation and use thereof in the treatment of inflammatory diseases 西特瑞治疗有限公司 2025-05-09 — — CN disclosed
Send feedback